PAPER Lopez E, Etxebarria-Elezgarai J, García-Sebastián M, Altuna M, Ecay-Torres M, Estanga A, Tainta M, López C, Martínez-Lage P, Amigo JM, Seifert A

Unlocking Preclinical Alzheimer's: A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics.

Int J Mol Sci. 2024 Apr 26;25(9) PubMed: 38731955

PAPER Vaibhav K, Gulhane M, Ahluwalia P, Kumar M, Ahluwalia M, Rafiq AM, Amble V, Zabala MG, Miller JB, Goldman L, Mondal AK, Deak F, Kolhe R, Arbab AS, Vale FL

Single episode of moderate to severe traumatic brain injury leads to chronic neurological deficits and Alzheimer's-like pathological dementia.

Geroscience. 2024 May 11; PubMed: 38733547

PAPER Serebrovska ZO, Serebrovska TV, Kholin VA, Tumanovska LV, Shysh AM, Pashevin DA, Goncharov SV, Stroy D, Grib ON, Shatylo VB, Bachinskaya NY, Egorov E, Xi L, Dosenko VE

RETRACTED: Serebrovska et al. Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Pilot Study. Int. J. Mol. Sci. 2019, 20, 5405.

Int J Mol Sci. 2024 May 7;25(9) PubMed: 38732274

PAPER Dörner M, Seebach K, Heneka MT, Menze I, von Känel R, Euler S, Schreiber F, Arndt P, Neumann K, Hildebrand A, John AC, Tyndall A, Kirchebner J, Tacik P, Jansen R, Grimm A, Henneicke S, Perosa V, Meuth SG, Peters O, Hellmann-Regen J, Preis L, Priller J, Spruth EJ, Schneider A, Fliessbach K, Wiltfang J, Jessen F, Rostamzadeh A, Glanz W, Schulze JB, Schiebler SL, Buerger K, Janowitz D, Perneczky R, Rauchmann BS, Teipel S, Kilimann I, Laske C, Munk MH, Spottke A, Roy-Kluth N, Wagner M, Frommann I, Lüsebrink F, Dechent P, Hetzer S, Scheffler K, Kleineidam L, Stark M, Schmid M, Ersözlü E, Brosseron F, Ewers M, Schott BH, Düzel E, Ziegler G, Mattern H, Schreiber S, Bernal J

Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age-Results from the Multicentre Observational DELCODE Study.

Diagnostics (Basel). 2024 Apr 30;14(9) PubMed: 38732354

PAPER Canet G, Gratuze M, Zussy C, Bouali ML, Diaz SD, Rocaboy E, Laliberté F, El Khoury NB, Tremblay C, Morin F, Calon F, Hébert SS, Julien C, Planel E

Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.

Neurobiol Dis. 2024 May 9;:106526. PubMed: 38734152

Go to another page:

1
2
3
4
5
... 22123

Current Filters

Date Range : All x

Remove all filters

SEARCH RESULTS

Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models.

Role of Bioactives in Neurodegenerative Diseases.

Diagnostic implications of ubiquitination-related gene signatures in Alzheimer's disease.

The Role of Structural Variants in the Genetic Architecture of Parkinson's Disease.

Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology and amyloidogenesis.

Novel Variants Linked to the Prodromal Stage of Parkinson's Disease (PD) Patients.

Reduced Expression of CLEC4G in Neurons Is Associated with Alzheimer's Disease.

The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges.

Protection of Si Nanowires against Aβ Toxicity by the Inhibition of Aβ Aggregation.

Monocytes release cystatin F dimer to associate with Aβ and aggravate amyloid pathology and cognitive deficits in Alzheimer's disease.